caption
stringlengths 6
2.51k
| molecule
stringlengths 1
747
| properties
sequencelengths 1
86
|
|---|---|---|
The molecule is a nutrient, a flavoring agent, and onion. The molecule is a emulsifier and a surfactant, as well as fruity and metallic. The molecule is tropical, vegetable, and musty. The molecule is a membrane stabilizer, a energy storage, a energy source, and sulfurous. | C=C(C)C1CCC(=C)C(OC(C)=O)C1 | [
"nutrient",
"onion",
"Flavoring agent",
"Emulsifier",
"fruity",
"surfactant",
"metallic",
"tropical",
"vegetable",
"musty",
"sulfurous",
"Membrane stabilizer",
"Energy storage",
"Energy source"
] |
The molecule is a signalling molecule, energy source, energy storage, membrane stabilizer. | CCCCCCCCC(=O)c1ccccc1 | [
"signalling molecule",
"Energy source",
"Energy storage",
"Membrane stabilizer"
] |
The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, cholesterol translocation that impacts diabetic heart disease and barth syndrome. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts tangier disease, non-alcoholic fatty liver disease, and aging. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)C | [
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Diabetic heart disease",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Aging",
"Apoptosis"
] |
The molecule is a nutrient that impacts ulcerative colitis, cervical cancer, atherosclerosis, and breast cancer. | CC/C=C\C/C=C\C/C=C\C/C=C\C[C@@H](O)[C@H](O)CCCC(=O)O[C@H](COC(=O)CCCCCCCC/C=C\C/C=C\C/C=C\CCCCCC)COP(=O)([O-])OCC[N+](C)(C)C | [
"nutrient",
"Ulcerative colitis",
"Cervical cancer",
"Atherosclerosis",
"Breast cancer"
] |
The molecule is a cholesterol translocation and a apoptosis that impacts aging, barth syndrome, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts tangier disease and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Aging",
"Cholesterol translocation",
"Barth syndrome",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase"
] |
The molecule is a nutrient, energy storage, inflammatory that belongs to the thyroxine treatment class of molecules and impacts both pancreatitis and metabolic syndrome. The molecule is a energy source and fat storage, and it impacts cardiovascular disease. The molecule is a membrane stabilizer that impacts atherosclerosis, obesity, and cancer. | CCCCCCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCC(C)C | [
"Pancreatitis",
"Thyroxine treatment",
"nutrient",
"Metabolic syndrome",
"Energy storage",
"inflammatory",
"Cardiovascular disease",
"Energy source",
"Fat storage",
"Atherosclerosis",
"Obesity",
"Membrane stabilizer",
"Cancer"
] |
The molecule is a optoelectronic and belongs to the organic electroluminescent material, organic optoelectronic device, and electroluminescent classes of molecules. | c1cc[nH]c1.c1ccc2cnncc2c1 | [
"organic electroluminescent material",
"organic optoelectronic device",
"electroluminescent",
"optoelectronic"
] |
The molecule is a cardiovascular disease treatment that is lxr modulator and metabolic disorder treatment. | CC(C)Oc1ccc(S(=O)(=O)N2c3ccccc3CC2C(=O)NCCc2ccccc2)cc1 | [
"lxr modulator",
"metabolic disorder treatment",
"cardiovascular disease treatment"
] |
The molecule is a membrane stabilizer, emulsifier, energy storage, surfactant, nutrient, energy source. | C=CCCCCCC(Cl)C(O)CC#CC#CC(O)C=C | [
"Membrane stabilizer",
"Emulsifier",
"Energy storage",
"surfactant",
"nutrient",
"Energy source"
] |
The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts aging, tangier disease, and barth syndrome. The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, apoptosis that impacts non-alcoholic fatty liver disease and diabetic heart disease. | CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | [
"Aging",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Tangier disease",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Apoptosis"
] |
The molecule is a nutrient. | CCCCCCCC/C=C\CCCCCCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C[C@H]1[C@@H](O)CC(O)O[C@@H]1/C=C/[C@@H](O)CCCCC)COP(=O)(O)OC[C@H](N)C(=O)O | [
"nutrient"
] |
The molecule is a stabilizing mitochondrial structure, apoptosis, cholesterol translocation that impacts barth syndrome and aging. The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, tangier disease, and diabetic heart disease. | CCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)CC | [
"Stabilizing mitochondrial structure",
"Apoptosis",
"Barth syndrome",
"Aging",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase"
] |
The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts barth syndrome, aging, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, apoptosis, cholesterol translocation that impacts tangier disease and non-alcoholic fatty liver disease. | CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | [
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Aging",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation"
] |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts tangier disease, barth syndrome, and aging. The molecule is a stabilizing cytochrome oxidase, apoptosis, cholesterol translocation that impacts non-alcoholic fatty liver disease and diabetic heart disease. | CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCC(C)C | [
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Barth syndrome",
"Aging",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease"
] |
The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase, apoptosis, cholesterol translocation that impacts aging and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)CC | [
"Barth syndrome",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Aging",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Apoptosis",
"Cholesterol translocation"
] |
The molecule is a immunomodulator, a aids treatment, and a hiv inhibitor. | Cc1ccc2[nH]c3c(Cl)ncnc3c2c1 | [
"immunomodulator",
"AIDs treatment",
"hiv inhibitor"
] |
The molecule is a apoptosis that impacts non-alcoholic fatty liver disease, tangier disease, diabetic heart disease, and aging. The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, stabilizing cytochrome oxidase, cholesterol translocation that impacts barth syndrome. | CCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCC(C)C | [
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Tangier disease",
"Diabetic heart disease",
"Aging",
"Proton trap for oxidative phosphorylation",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation"
] |
The molecule is fluorescent. | CC(N=C(N=C(N)c1ccccc1)c1cccc(-n2c3c(c4cc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)ccc42)CCC=C3)c1)c1ccccc1 | [
"fluorescent"
] |
It belongs to the tachykinin antagonist class of molecules. | Cl.O=C(c1ccccc1)C1CC2(c3ccccc3)NC1CCC2OCc1cc(C(F)(F)F)cc(C(F)(F)F)c1 | [
"tachykinin antagonist"
] |
The molecule is both a platelet aggregation inhibitor and a cardiovascular treatment. | O=S(=O)(NCCc1ccc(Nc2nn[nH]n2)cc1)c1ccc(Cl)cc1 | [
"platelet aggregation inhibitor",
"cardiovascular treatment"
] |
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, apoptosis that impacts aging and tangier disease. The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts barth syndrome, diabetic heart disease, and non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"Cholesterol translocation",
"Aging",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease"
] |
The molecule is a energy storage and fat storage, affecting cancer, and impacting obesity, metabolic syndrome, and pancreatitis. The molecule is a inflammatory, a membrane stabilizer, and a energy source. The molecule is a nutrient and belongs to the thyroxine treatment class of molecules, impacting both cardiovascular disease and atherosclerosis. | CCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)CC | [
"Obesity",
"Metabolic syndrome",
"Energy storage",
"Fat storage",
"Cancer",
"Pancreatitis",
"inflammatory",
"Membrane stabilizer",
"Energy source",
"Cardiovascular disease",
"Thyroxine treatment",
"Atherosclerosis",
"nutrient"
] |
The molecule is a nutritional supplement, a proton trap for oxidative phosphorylation, and a energy storage, and it impacts tangier disease. The molecule is a apoptosis, a cholesterol translocation, and a surfactant, it impacts barth syndrome and is smooth. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a energy source, membrane stabilizer, emulsifier, food additive that impacts aging. | CCC(C)CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)C | [
"Nutritional supplement",
"Proton trap for oxidative phosphorylation",
"Energy storage",
"Tangier disease",
"Apoptosis",
"Barth syndrome",
"Cholesterol translocation",
"Smooth",
"surfactant",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Energy source",
"Membrane stabilizer",
"Emulsifier",
"food additive",
"Aging"
] |
The molecule is a nutrient, fat storage, and membrane stabilizer that has an effect on cancer and impacts both metabolic syndrome and cardiovascular disease. It impacts obesity, atherosclerosis, and pancreatitis. The molecule is a energy source, a energy storage, a inflammatory, and thyroxine treatment. | CCC(C)CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC | [
"nutrient",
"Fat storage",
"Cancer",
"Membrane stabilizer",
"Metabolic syndrome",
"Cardiovascular disease",
"Obesity",
"Atherosclerosis",
"Pancreatitis",
"Energy source",
"Energy storage",
"inflammatory",
"Thyroxine treatment"
] |
The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts aging, diabetic heart disease, and tangier disease. The molecule is a stabilizing mitochondrial structure, apoptosis, stabilizing cytochrome oxidase that impacts barth syndrome and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCC(C)C | [
"Aging",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Non-alcoholic fatty liver disease"
] |
The molecule is anti biotic. | CCN(CC(C)(C)N)C(C)c1ccccc1OC | [
"anti biotic"
] |
The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, and aging. The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, apoptosis that impacts barth syndrome and diabetic heart disease. | CCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC | [
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Aging",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Diabetic heart disease"
] |
The molecule is a nutrient. | CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCC/C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]1O)COP(=O)(O)OC[C@H](N)C(=O)O | [
"nutrient"
] |
It belongs to the electronic device class of molecules. | CC(C)(C)c1ccc(N(c2ccc(-c3ccc(O)cc3)cc2)c2ccc(C(C)(C)C)cc2)cc1 | [
"electronic device"
] |
The molecule is both a asthma treatment and a tnf inhibitor. | C1CC2CC1O2.COC(=O)C(=O)NC(C)c1ccccc1OC | [
"asthma treatment",
"tnf inhibitor"
] |
The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, proton trap for oxidative phosphorylation, apoptosis that impacts diabetic heart disease. The molecule is a stabilizing mitochondrial structure that impacts barth syndrome, tangier disease, aging, and non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Apoptosis",
"Barth syndrome",
"Tangier disease",
"Aging",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease"
] |
The molecule has Ammoniacal odor. | CCN1CCOCC1 | [
"Odor_evaluation"
] |
The molecule is a hepatoprotective and anti neoplastic agent, belonging to the anti oxidant class of molecules, and is both anti radicular and anti nf-kappa-b. The molecule is a immunological adjuvant, anti cancer, and hypocholesterolemic, belonging to the anti hepatotoxic class of molecules, and is both roasted and anti tumor. The molecule is anti proliferant, cooked, and mucokinetic; additionally, it is anti melanomic and anti neuroblastomic. The molecule is a nutrient, glutathione-sparing, squalene-monooxygenase inhibitor, anti cholesterogenic and belongs to the anti aging and anti atherogenic classes of molecules. | COc1cc(O)c2c(c1-c1c(OC)cc(O)c3c1C(=O)c1c(O)c(C)cc(O)c1C3=O)C(=O)c1c(O)c(C)cc(O)c1C2=O | [
"anti oxidant",
"anti radicular",
"hepatoprotective",
"anti NF-kappa-B",
"anti neoplastic agent",
"roasted",
"immunological adjuvant",
"anti cancer",
"anti hepatotoxic",
"hypocholesterolemic",
"anti tumor",
"anti proliferant",
"cooked",
"mucokinetic",
"anti melanomic",
"anti neuroblastomic",
"nutrient",
"glutathione-sparing",
"anti aging",
"squalene-monooxygenase inhibitor",
"anti cholesterogenic",
"anti atherogenic"
] |
The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis that impacts tangier disease and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts diabetic heart disease, barth syndrome, and aging. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCCCCCC | [
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Cholesterol translocation",
"Barth syndrome",
"Aging",
"Stabilizing mitochondrial structure"
] |
The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts diabetic heart disease, tangier disease, and barth syndrome. The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, cholesterol translocation that impacts non-alcoholic fatty liver disease and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCC | [
"Diabetic heart disease",
"Apoptosis",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Aging"
] |
The molecule is a nutrient and a fat storage that impacts atherosclerosis, metabolic syndrome, pancreatitis, and cancer. The molecule is a energy storage and energy source, and it impacts cardiovascular disease. The molecule is a inflammatory and a membrane stabilizer, it impacts obesity, and is thyroxine treatment. | CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"nutrient",
"Atherosclerosis",
"Metabolic syndrome",
"Pancreatitis",
"Fat storage",
"Cancer",
"Cardiovascular disease",
"Energy storage",
"Energy source",
"inflammatory",
"Obesity",
"Thyroxine treatment",
"Membrane stabilizer"
] |
The molecule is a cholesterol translocation, apoptosis, stabilizing cytochrome oxidase that impacts barth syndrome and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts tangier disease, non-alcoholic fatty liver disease, and aging. | CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCC(C)C | [
"Barth syndrome",
"Cholesterol translocation",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Aging",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure"
] |
The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts aging, diabetic heart disease, and barth syndrome. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, cholesterol translocation that impacts non-alcoholic fatty liver disease and tangier disease. | CC/C=C\C/C=C\C/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC | [
"Aging",
"Apoptosis",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Tangier disease"
] |
The molecule is a monoamine reuptake inhibitor. | CNCCCC1Cc2cc(F)ccc2N(c2c(F)cccc2F)S1(=O)=O | [
"monoamine reuptake inhibitor"
] |
The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, tangier disease, and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, cholesterol translocation, apoptosis that impacts aging and barth syndrome. | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC | [
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Aging",
"Cholesterol translocation",
"Apoptosis",
"Barth syndrome"
] |
The molecule is a nutrient and is peanut. The molecule has At high levels (e.g., 1000 ppm emulsion in water) it has a mild, fruity, non-descript flavor.. The molecule has Odorless. When heated to decomposition it emits acrid smoke and irritating vapors. The molecule is a flavoring agent which is overripe fruit, juicy, and sweet; further, it is banana and fruit. | CCCCOC(=O)CC(CC(=O)OCCCC)(OC(C)=O)C(=O)OCCCC | [
"nutrient",
"peanut",
"taste_evaluation",
"Odor_evaluation",
"Decomposition_evaluation",
"overripe fruit",
"Flavoring agent",
"juicy",
"sweet",
"banana",
"fruit"
] |
The molecule is a nutrient that impacts alzheimer's disease, diabetes mellitus type 2, parkinson's disease, and non-alcoholic fatty liver disease. | CCCCC/C=C\C[C@H](O)/C=C/C=C\C/C=C\CCCC(=O)O[C@H](CO/C=C/CCCCCC/C=C\CCCCCCCC)COP(=O)(O)OCCN | [
"Alzheimer's Disease",
"Diabetes mellitus type 2",
"Parkinson's disease",
"nutrient",
"Non-alcoholic fatty liver disease"
] |
The molecule is a membrane stabilizer, a nutritional supplement, and a emulsifier, and it impacts barth syndrome. The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase, which impacts both aging and diabetic heart disease, and is characterized as smooth. The molecule is a stabilizing mitochondrial structure, food additive, surfactant, apoptosis. The molecule is a energy storage, proton trap for oxidative phosphorylation, energy source that impacts non-alcoholic fatty liver disease and tangier disease. | CCC(C)CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC(C)C | [
"Membrane stabilizer",
"Nutritional supplement",
"Emulsifier",
"Barth syndrome",
"Smooth",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Aging",
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"food additive",
"surfactant",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Energy storage",
"Proton trap for oxidative phosphorylation",
"Energy source"
] |
The molecule is a anti body drug conjugate member of the anti body class. | CCC(=O)NCCOCCOCCOCCNC(=O)c1ccc(C(=O)NCCCCCCc2cn(CCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)nn2)cc1 | [
"anti body",
"anti body drug conjugate"
] |
The molecule is a energy storage, a nutrient, and a energy source, which has an effect on cancer and impacts metabolic syndrome, and is thyroxine treatment. The molecule is a fat storage that impacts both atherosclerosis and cardiovascular disease. The molecule is a inflammatory and a membrane stabilizer, impacting both obesity and pancreatitis. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC | [
"Cancer",
"Energy storage",
"Metabolic syndrome",
"nutrient",
"Energy source",
"Thyroxine treatment",
"Fat storage",
"Atherosclerosis",
"Cardiovascular disease",
"Obesity",
"inflammatory",
"Pancreatitis",
"Membrane stabilizer"
] |
It belongs to the pain treatment class of molecules. | CC(C)CN1C2C=CCCC1CC(C(C)C)C2 | [
"pain treatment"
] |
The molecule is a anti cancer, anti cancer agent, kinase inhibitor, protein kinase inhibitor. | CC(C)(O)C(=O)N1CC(N2CCN(c3cc(C#N)cc(Nc4nc(NC5CC5)c5ncc(C#N)n5n4)c3Cl)CC2)C1 | [
"anti cancer",
"anti cancer agent",
"kinase inhibitor",
"protein kinase inhibitor"
] |
The molecule is a thyroxine treatment and membrane stabilizer, affecting cancer, and impacting pancreatitis, obesity, and metabolic syndrome. The molecule is a inflammatory and energy storage, and it impacts atherosclerosis. The molecule is a energy source, a fat storage, and a nutrient, and it impacts cardiovascular disease. | CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCC | [
"Cancer",
"Pancreatitis",
"Thyroxine treatment",
"Membrane stabilizer",
"Obesity",
"Metabolic syndrome",
"Atherosclerosis",
"inflammatory",
"Energy storage",
"Cardiovascular disease",
"Energy source",
"Fat storage",
"nutrient"
] |
The molecule is a surfactant and a energy source, impacting both diabetic heart disease and aging. The molecule is a stabilizing mitochondrial structure, a emulsifier, and a nutritional supplement, it impacts tangier disease and is smooth. The molecule is a cholesterol translocation, a stabilizing cytochrome oxidase, and a membrane stabilizer, and it impacts barth syndrome. The molecule is a energy storage, food additive, apoptosis, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease. | CCC(C)CCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)CC | [
"Diabetic heart disease",
"surfactant",
"Energy source",
"Aging",
"Stabilizing mitochondrial structure",
"Emulsifier",
"Tangier disease",
"Nutritional supplement",
"Smooth",
"Barth syndrome",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Membrane stabilizer",
"Energy storage",
"food additive",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease"
] |
The molecule is a energy storage, energy source, membrane stabilizer, inflammatory that impacts metabolic syndrome and pancreatitis. The molecule is a nutrient that affects cancer by impacting atherosclerosis. The molecule is a thyroxine treatment and a fat storage, impacting both obesity and cardiovascular disease. | CCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCC(C)C | [
"Metabolic syndrome",
"Energy storage",
"Pancreatitis",
"Energy source",
"Membrane stabilizer",
"inflammatory",
"Atherosclerosis",
"Cancer",
"nutrient",
"Obesity",
"Cardiovascular disease",
"Thyroxine treatment",
"Fat storage"
] |
It has an effect on both improved luminous efficiency and low driving voltage, and impacts luminous efficiency. | CN=C(N=C(N)c1cccc(-c2ccccc2)c1)c1ccccc1 | [
"luminous efficiency",
"improved luminous efficiency",
"low driving voltage"
] |
It influences both colorectal cancer and stomach cancer, as well as affecting cardiovascular disease and breast cancer. It impacts parkinson's disease, seizure, alzheimer's disease, and diabetes mellitus. | CCCCCCCC/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C=C\[C@H](O)CCCCC)COP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O | [
"Colorectal cancer",
"Stomach cancer",
"Cardiovascular disease",
"Breast cancer",
"Parkinson's disease",
"Seizure",
"Alzheimer's Disease",
"Diabetes mellitus"
] |
The molecule is a membrane stabilizer, inflammatory, energy source, energy storage that has an effect on lipotoxicity and impacts metabolic syndrome. | CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)COC(=O)CCCCCCCCCC(C)C | [
"Metabolic syndrome",
"Lipotoxicity",
"Membrane stabilizer",
"inflammatory",
"Energy source",
"Energy storage"
] |
The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts aging, tangier disease, and barth syndrome. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, apoptosis that impacts non-alcoholic fatty liver disease and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Cholesterol translocation",
"Aging",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Apoptosis"
] |
The molecule is a cholesterol translocation, apoptosis, proton trap for oxidative phosphorylation that impacts barth syndrome and tangier disease. The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, diabetic heart disease, and aging. | CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCC(C)CC | [
"Barth syndrome",
"Cholesterol translocation",
"Apoptosis",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Aging"
] |
The molecule is a food additive, energy source, apoptosis, cholesterol translocation. The molecule is a nutritional supplement, stabilizing cytochrome oxidase, surfactant, stabilizing mitochondrial structure, emulsifier. The molecule is a energy storage, a proton trap for oxidative phosphorylation, and a membrane stabilizer, and it impacts tangier disease. It impacts barth syndrome, non-alcoholic fatty liver disease, diabetic heart disease, and aging, and the molecule is smooth. | CCC(C)CCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)CC | [
"food additive",
"Energy source",
"Apoptosis",
"Cholesterol translocation",
"Nutritional supplement",
"Stabilizing cytochrome oxidase",
"surfactant",
"Stabilizing mitochondrial structure",
"Emulsifier",
"Energy storage",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Membrane stabilizer",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Smooth",
"Aging"
] |
The molecule is a asthma treatment. | CCCn1c(=O)c2[nH]c(-c3ccc(N(CC4CCCO4)C(=O)Nc4ccc(F)cc4)nc3)cc2n(CCC)c1=O | [
"asthma treatment"
] |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, aging, and barth syndrome. The molecule is a cholesterol translocation, apoptosis, stabilizing mitochondrial structure that impacts tangier disease and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC | [
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation",
"Aging",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Apoptosis",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Diabetic heart disease"
] |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, apoptosis that impacts non-alcoholic fatty liver disease and tangier disease. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation that impacts barth syndrome, aging, and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC | [
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Apoptosis",
"Barth syndrome",
"Aging",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease"
] |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, barth syndrome, and aging. The molecule is a stabilizing mitochondrial structure, cholesterol translocation, apoptosis that impacts tangier disease and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCC | [
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Aging",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Tangier disease",
"Apoptosis",
"Diabetic heart disease"
] |
The molecule is a flt3 inhibitor and belongs to the kinase modulator class of molecules. | COc1ccccc1-c1[nH]nc2ncc(-c3ccc(C(=O)N4CCOCC4)nc3)cc12 | [
"kinase modulator",
"flt3 inhibitor"
] |
The molecule is a nutrient that affects breast cancer by impacting cervical cancer, atherosclerosis, and ulcerative colitis. | CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](SC[C@H](N)C(=O)O[C@H](COC(=O)CCCCCCCCc1oc(CCC)c(C)c1C)COP(=O)([O-])OCC[N+](C)(C)C)[C@@H](O)CCCC(=O)O | [
"Cervical cancer",
"nutrient",
"Breast cancer",
"Atherosclerosis",
"Ulcerative colitis"
] |
The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, cholesterol translocation that impacts aging and tangier disease. The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts barth syndrome, diabetic heart disease, and non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Aging",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Barth syndrome",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease"
] |
The molecule is a thyroxine treatment and fat storage, and it impacts metabolic syndrome. The molecule is a nutrient that impacts pancreatitis, cardiovascular disease, and atherosclerosis. | CCCCCCCC/C=C\CCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC | [
"Thyroxine treatment",
"Fat storage",
"Metabolic syndrome",
"Pancreatitis",
"Cardiovascular disease",
"nutrient",
"Atherosclerosis"
] |
The molecule is a cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts diabetic heart disease and barth syndrome. The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts tangier disease, aging, and non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Diabetic heart disease",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Tangier disease",
"Aging",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase"
] |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase that impacts diabetic heart disease, barth syndrome, and aging. The molecule is a cholesterol translocation, stabilizing mitochondrial structure, apoptosis that impacts tangier disease and non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC | [
"Diabetic heart disease",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Aging",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Apoptosis"
] |
The molecule is a surfactant and a proton trap for oxidative phosphorylation, impacting both diabetic heart disease and aging. The molecule is a energy storage, nutritional supplement, apoptosis that impacts tangier disease and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, emulsifier, cholesterol translocation. The molecule is a energy source, a membrane stabilizer, and a food additive, it impacts barth syndrome and is smooth. | CCCCCC/C=C\C=C/CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C | [
"Diabetic heart disease",
"Aging",
"surfactant",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Energy storage",
"Nutritional supplement",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Emulsifier",
"Cholesterol translocation",
"Energy source",
"Smooth",
"Barth syndrome",
"Membrane stabilizer",
"food additive"
] |
The molecule is a nutrient that affects breast cancer by impacting cervical cancer, ulcerative colitis, and atherosclerosis. | CC/C=C\C/C=C\C/C=C\C/C=C\C[C@H](O)[C@@H](O)CCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCC/C=C\C/C=C\C/C=C\CCCCC | [
"nutrient",
"Breast cancer",
"Cervical cancer",
"Ulcerative colitis",
"Atherosclerosis"
] |
The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, cholesterol translocation that impacts aging and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Aging",
"Cholesterol translocation",
"Barth syndrome"
] |
The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts diabetic heart disease, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, apoptosis that impacts tangier disease and aging. | CC/C=C\C/C=C\C/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC | [
"Diabetic heart disease",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Aging",
"Apoptosis"
] |
The molecule is both a anti inflammatory and a cyclooxygenase2 inhibitor. | CCOC(=O)CC(c1c(C)[nH]c2ccc(OC)cc12)C(F)(F)F | [
"anti inflammatory",
"cyclooxygenase2 inhibitor"
] |
The molecule is a nutrient that impacts non-alcoholic fatty liver disease, alzheimer's disease, parkinson's disease, and diabetes mellitus type 2. | CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCC[C@@H](C)O)COP(=O)(O)OCCN | [
"Non-alcoholic fatty liver disease",
"Alzheimer's Disease",
"Parkinson's disease",
"nutrient",
"Diabetes mellitus type 2"
] |
The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, stabilizing cytochrome oxidase, cholesterol translocation that impacts non-alcoholic fatty liver disease. The molecule is a apoptosis that impacts diabetic heart disease, aging, barth syndrome, and tangier disease. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Apoptosis",
"Aging",
"Barth syndrome",
"Tangier disease"
] |
The molecule is a apoptosis, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts aging and tangier disease. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, barth syndrome, and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC(C)C | [
"Aging",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Barth syndrome",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a angiogenesis inhibitor that impacts hyperproliferative disease treatment. | CCCCCc1nc(N)c2ccoc2n1 | [
"hyperproliferative disease treatment",
"angiogenesis inhibitor"
] |
The molecule is a proton trap for oxidative phosphorylation, cholesterol translocation, stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease and tangier disease. The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts aging, diabetic heart disease, and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Aging",
"Diabetic heart disease",
"Barth syndrome",
"Apoptosis"
] |
The molecule is a fat storage, inflammatory, energy source, membrane stabilizer, nutrient that impacts thyroxine treatment. It impacts cancer, pancreatitis, and obesity. The molecule is a energy storage that impacts cardiovascular disease, atherosclerosis, and metabolic syndrome. | CCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCC(C)C | [
"Fat storage",
"inflammatory",
"Energy source",
"Membrane stabilizer",
"nutrient",
"Thyroxine treatment",
"Cancer",
"Pancreatitis",
"Obesity",
"Cardiovascular disease",
"Energy storage",
"Atherosclerosis",
"Metabolic syndrome"
] |
The molecule is a fat storage, membrane stabilizer, and inflammatory that has an effect on cancer and impacts both obesity and thyroxine treatment. The molecule is a nutrient and energy source, and it impacts metabolic syndrome. The molecule is a energy storage that impacts pancreatitis, atherosclerosis, and cardiovascular disease. | CCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | [
"Fat storage",
"Cancer",
"Membrane stabilizer",
"Obesity",
"inflammatory",
"Thyroxine treatment",
"Metabolic syndrome",
"nutrient",
"Energy source",
"Pancreatitis",
"Energy storage",
"Atherosclerosis",
"Cardiovascular disease"
] |
The molecule is optoelectronic. | CCCC1COC(c2ccc(C#CC(F)(F)F)c(F)c2)OC1 | [
"optoelectronic"
] |
The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, cholesterol translocation that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts aging, tangier disease, and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\CCCCCC | [
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Diabetic heart disease",
"Aging",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Barth syndrome",
"Apoptosis"
] |
The molecule is a thyroxine treatment that impacts both atherosclerosis and cardiovascular disease. The molecule is a nutrient and a fat storage, impacting both pancreatitis and metabolic syndrome. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCC/C=C\C/C=C\C/C=C\CCCCC | [
"Atherosclerosis",
"Cardiovascular disease",
"Thyroxine treatment",
"Pancreatitis",
"nutrient",
"Fat storage",
"Metabolic syndrome"
] |
It belongs to the cancer treatment class of molecules. | O=C(C=Cc1ccc(C(C(=O)O)c2ccc3ocnc3c2)c(F)c1)Nc1ccc(F)c(Cl)c1 | [
"cancer treatment"
] |
The molecule is a apoptosis, cholesterol translocation, stabilizing cytochrome oxidase that impacts diabetic heart disease and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts aging, non-alcoholic fatty liver disease, and tangier disease. | CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C | [
"Diabetic heart disease",
"Barth syndrome",
"Apoptosis",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Aging",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Stabilizing mitochondrial structure"
] |
The molecule is a anti bodydrug conjugate and is anti tumor. | CCNC(=O)C(Cc1ccccc1)C(=O)CNC(=O)CCCCCN | [
"anti bodydrug conjugate",
"anti tumor"
] |
The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts tangier disease, aging, and diabetic heart disease. The molecule is a stabilizing mitochondrial structure, cholesterol translocation, stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease and barth syndrome. | CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCC(C)C | [
"Apoptosis",
"Tangier disease",
"Aging",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Barth syndrome",
"Stabilizing cytochrome oxidase"
] |
The molecule is a protease inhibitor. | CNCC(CC1CCCCC1)NC(=O)N1CCCC(C(CCCCOC)(OCCCO)c2cccc(Cl)c2)C1 | [
"protease inhibitor"
] |
The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, apoptosis that impacts non-alcoholic fatty liver disease and tangier disease. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts diabetic heart disease, barth syndrome, and aging. | CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | [
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Barth syndrome",
"Aging"
] |
The molecule is a energy storage and a proton trap for oxidative phosphorylation, impacting both aging and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, a membrane stabilizer, and a surfactant, it impacts barth syndrome and is smooth. The molecule is a food additive, a stabilizing mitochondrial structure, and a nutritional supplement, and it impacts non-alcoholic fatty liver disease. The molecule is a energy source, emulsifier, cholesterol translocation, apoptosis that impacts tangier disease. | CCC(C)CCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCC(C)C | [
"Energy storage",
"Aging",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Smooth",
"Membrane stabilizer",
"surfactant",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"food additive",
"Stabilizing mitochondrial structure",
"Nutritional supplement",
"Energy source",
"Emulsifier",
"Tangier disease",
"Cholesterol translocation",
"Apoptosis"
] |
It impacts colorectal cancer, breast cancer, parkinson's disease, and cardiovascular disease. It impacts stomach cancer, seizure, diabetes mellitus, and alzheimer's disease. | CCCCCC/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCC[C@@H](C)O)COP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O | [
"Colorectal cancer",
"Breast cancer",
"Parkinson's disease",
"Cardiovascular disease",
"Stomach cancer",
"Seizure",
"Diabetes mellitus",
"Alzheimer's Disease"
] |
The molecule is a fat storage, energy storage, inflammatory, membrane stabilizer that has an effect on cancer and impacts obesity. The molecule is thyroxine treatment and it impacts both metabolic syndrome and pancreatitis. The molecule is a nutrient and a energy source, impacting both cardiovascular disease and atherosclerosis. | CCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCC(C)CC | [
"Fat storage",
"Energy storage",
"Obesity",
"Cancer",
"inflammatory",
"Membrane stabilizer",
"Thyroxine treatment",
"Metabolic syndrome",
"Pancreatitis",
"nutrient",
"Cardiovascular disease",
"Atherosclerosis",
"Energy source"
] |
The molecule is a kinase inhibitor. | Cc1cnc(-c2ccc(-c3ccc(NC(=O)c4cc(F)cc(N5CCOCC5)c4)cc3F)c3c2C(=O)NC3)[nH]1 | [
"kinase inhibitor"
] |
The molecule is a inflammatory, energy storage, energy source, belonging to the thyroxine treatment class of molecules, and it has an effect on cancer as well as impacts pancreatitis. The molecule is a nutrient and membrane stabilizer, and it impacts cardiovascular disease. The molecule is a fat storage that impacts atherosclerosis, metabolic syndrome, and obesity. | CCCCCCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCCCC(C)CC | [
"inflammatory",
"Pancreatitis",
"Thyroxine treatment",
"Energy storage",
"Energy source",
"Cancer",
"nutrient",
"Membrane stabilizer",
"Cardiovascular disease",
"Atherosclerosis",
"Metabolic syndrome",
"Fat storage",
"Obesity"
] |
The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, apoptosis that impacts diabetic heart disease and barth syndrome. The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, aging, and tangier disease. | CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C | [
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Barth syndrome",
"Apoptosis",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Aging",
"Tangier disease"
] |
The molecule is both a ns5a inhibitor and a hcv inhibitor. | COC(=O)NC(C(=O)N1CC(OC)CC1c1ncc(-c2ccc(-c3cc(Cl)c(NC(=O)c4ccc(N5CCNCC5C)nc4)cc3OC(F)(F)F)cc2)[nH]1)C1CCOCC1 | [
"ns5a inhibitor",
"hcv inhibitor"
] |
The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, apoptosis that impacts barth syndrome and aging. The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts tangier disease, non-alcoholic fatty liver disease, and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCC | [
"Cholesterol translocation",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Aging",
"Apoptosis",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Diabetic heart disease"
] |
The molecule is a energy source, inflammatory, and nutrient that has an effect on cancer and impacts both metabolic syndrome and atherosclerosis. The molecule is a energy storage and fat storage, and it impacts pancreatitis. The molecule is a membrane stabilizer and thyroxine treatment, impacting both obesity and cardiovascular disease. | CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)COC(=O)CCCCCCCCCC(C)C | [
"Metabolic syndrome",
"Atherosclerosis",
"Energy source",
"inflammatory",
"Cancer",
"nutrient",
"Energy storage",
"Pancreatitis",
"Fat storage",
"Membrane stabilizer",
"Thyroxine treatment",
"Obesity",
"Cardiovascular disease"
] |
The molecule is both a obesity treatment and a hiv inhibitor. | CC(=O)Cc1cccc2c(C)cccc12 | [
"obesity treatment",
"hiv inhibitor"
] |
The molecule is a kinase inhibitor and angiogenesis inhibitor, belonging to the anti cancer class of molecules, and is hyperproliferative disorder treatment. | CC(N)COc1ccc2ncc(-c3cc4c(N5CCOCC5C)nccc4o3)n2n1 | [
"kinase inhibitor",
"angiogenesis inhibitor",
"anti cancer",
"hyperproliferative disorder treatment"
] |
The molecule is a cancer treatment. | Cc1cc(-c2cnc(N)c(OCc3cc(Cl)ncc3F)n2)cc2c1CCN(C)C2 | [
"cancer treatment"
] |
The molecule is a nutrient and a inflammatory that impacts obesity, cardiovascular disease, metabolic syndrome, and pancreatitis. The molecule is a energy storage and fat storage with an effect on cancer. The molecule is a membrane stabilizer, a energy source, and a thyroxine treatment, and it impacts atherosclerosis. | CCC(C)CCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCC(C)C | [
"Obesity",
"Cardiovascular disease",
"Metabolic syndrome",
"Pancreatitis",
"nutrient",
"inflammatory",
"Energy storage",
"Cancer",
"Fat storage",
"Membrane stabilizer",
"Energy source",
"Thyroxine treatment",
"Atherosclerosis"
] |